Aperture Investors, LLC - FINCH THERAPEUTICS GROUP INC ownership

FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 47 filers reported holding FINCH THERAPEUTICS GROUP INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Aperture Investors, LLC ownership history of FINCH THERAPEUTICS GROUP INC
ValueSharesWeighting
Q3 2022$322,000
-45.4%
192,794
-7.2%
0.05%
-45.9%
Q2 2022$590,000
-39.9%
207,729
+6.4%
0.10%
-22.8%
Q1 2022$982,000
-49.5%
195,2290.0%0.13%
-49.2%
Q4 2021$1,946,000
-35.5%
195,229
-15.8%
0.25%
-38.3%
Q3 2021$3,016,000
-32.8%
231,991
-27.3%
0.40%
-21.1%
Q2 2021$4,490,000
-39.9%
319,122
-32.0%
0.51%
-55.2%
Q1 2021$7,471,000469,5841.15%
Other shareholders
FINCH THERAPEUTICS GROUP INC shareholders Q2 2021
NameSharesValueWeighting ↓
TRB Advisors LP 550,000$7,739,0001.75%
Bleichroeder LP 810,416$11,403,0001.72%
Aperture Investors, LLC 319,122$4,490,0000.51%
Ikarian Capital, LLC 325,000$4,573,0000.37%
SECTORAL ASSET MANAGEMENT INC 300,399$4,227,0000.34%
Baupost Group 1,208,159$16,693,0000.14%
Proficio Capital Partners LLC 112,059$1,577,0000.12%
LIGHT STREET CAPITAL MANAGEMENT, LLC 168,330$2,368,0000.10%
MSD Partners, L.P. 235,294$3,311,0000.09%
PURA VIDA INVESTMENTS, LLC 71,552$1,007,0000.03%
View complete list of FINCH THERAPEUTICS GROUP INC shareholders